Ben Lamm
Co-Founder and CEO @ Colossal Biosciences
Austin, United States
Ben Lamm is a seed investor at Colossal Biosciences in Austin focused on Software and Artificial Intelligence. Ben Lamm is based out of Dallas, Texas and is the Co-Founder and CEO of Colossal Biosciences. He previously worked at Hypergiant as a Founder & Board Member. Ben Lamm attened the Baylor University.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries Ben Lamm invests in
Stages Ben Lamm invests in
Countries Ben Lamm invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.5M–$9.2M
- Series A
- $3M–$10M
Investment Focus
Industry
- Software 5 (29%)
- Artificial Intelligence 3 (18%)
- SaaS 2 (12%)
- Sports 2 (12%)
- Computer 2 (12%)
Stage
- Seed 6 (35%)
- Series A 3 (18%)
- Funding Round 3 (18%)
- Angel 2 (12%)
- Pre-Seed 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Colossal Foundation is dedicated to supporting the use of cutting-edge technologies in conservation efforts globally to help prevent the extinction of keystone species. | $50M / Oct 01, 2025 | ||
| Carbon Counts is creating a Play-to-Plant game called EverForest that will inspire millions of people to take individual and collective action to combat climate change. The mobile gameplay will have an impact on the real world as users play in the EverForest. Because the company plants, grows, and protects trees in the real world on their behalf asthey grow forests and make them flourish in-game. It collaborates with some of the world's most progressive organizations to help regenerate thriving ecosystems. | $4.5M / Seed / Aug 24, 2022 | ||
| Prima is a best-in-class, purpose-driven holistic wellness brand elevating hemp-based CBD and functionally innovative botanicals. Its core mission is to rise up against the modern day stress epidemic through education and products made with the highest standards of purity, potency and transparency. Prima is built on the essential principle thatbalance is a critical part of health and happiness — and that we all deserve better. Prima is a privately held Public Benefit Corporation (PBC) based in Santa Monica, CA. | $9.2M / Seed / May 21, 2021 | ||
| AnthemIQ builds technology that helps commercial real estate brokers manage their deals from search to signed lease. The company's simplified digital workflow moves people away from their inboxes and into AIQ's unified messaging thread. From comments to tours to proposals, tenant representatives and leasing agents collaborate in real-timeto reach an agreement and sign a contract. They automate leasing activity reports for them, and the quality of the prospects improves as the space is thoroughly vetted before a tour. | $10M / Series A / May 10, 2021 | ||
| WIN Reality optimizes mental performance and prepares athletes for competition. WIN Reality software is used by Professional, Collegiate, and High School organizations worldwide to quantify performance potential, and transfer training improvements into competition. | Seed / Feb 10, 2021 | ||
| Carbon Counts is creating a Play-to-Plant game called EverForest that will inspire millions of people to take individual and collective action to combat climate change. The mobile gameplay will have an impact on the real world as users play in the EverForest. Because the company plants, grows, and protects trees in the real world on their behalf asthey grow forests and make them flourish in-game. It collaborates with some of the world's most progressive organizations to help regenerate thriving ecosystems. | $2.5M / Pre-Seed / Feb 06, 2021 | ||
| Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before. | $10M / Series A / Feb 06, 2020 | ||
| First Dollar is a healthcare savings platform with a focus on HSAs (health savings accounts) that targets millennials and Gen Z. | Angel / Dec 08, 2019 | ||
| Nautilus Magazine is a new literary science magazine that addresses a single topic in science from multiple vantage points of math, biology, and physics to philosophy, culture, and the arts, through each magazine issue. Each month it chooses a single topic and each Thursday it publishes a new chapter on that topic online. Each issue combines thesciences, culture, and philosophy into a single story told by professional thinkers and writers.Nautilus Magazine provides essays, investigative reports, blogs, games, videos, and graphic stories for its users. It recognizes the unity of science, philosophy, and the humanities.Nautilus Magazine was first published in 2012 and is based in New York, N.Y. | Dec 27, 2018 | ||
| Hypergiant Sensory Sciences is use AI to help companies understand their physical environments | $5M / Seed / Nov 30, 2018 | ||
| See all 17 investments → | |||
Co-Investors
About Colossal Biosciences
Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology.
Colossal Biosciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
George Church
Co-Founder
|
|||
Sarah Grant
Chief of staff
|
|||
Andrew Busey
Co-Founder and Chief Product Officer
|
|||
|
Ben Lamm
Co-Founder and CEO
|
|||
Daniel Breyer
Investor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Ben Lamm invest in?
Ben Lamm invests primarily in Software, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ben Lamm's check size?
Ben Lamm typically joins rounds of $1.5M–$9.2M at Seed and $3M–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ben Lamm participates in.
How do I contact Ben Lamm?
Public channels for Ben Lamm include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ben Lamm last invest?
The most recent investment recorded for Ben Lamm closed in Oct 2025. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
